2018
BmGPAC, an Antigen Capture Assay for Detection of Active Babesia microti Infection
Thekkiniath J, Mootien S, Lawres L, Perrin BA, Gewirtz M, Krause PJ, Williams S, Doggett J, Ledizet M, Mamoun C. BmGPAC, an Antigen Capture Assay for Detection of Active Babesia microti Infection. Journal Of Clinical Microbiology 2018, 56: 10.1128/jcm.00067-18. PMID: 30093394, PMCID: PMC6156295, DOI: 10.1128/jcm.00067-18.Peer-Reviewed Original ResearchConceptsHuman babesiosisBabesia microti infectionCapture enzyme-linked immunosorbent assayAntigen capture enzyme-linked immunosorbent assayAntigen capture assayEnzyme-linked immunosorbent assayZoonotic infectious diseaseAcute infectionBlood transfusionAsymptomatic infectionMicroti infectionReal-time PCRBlood supplyAnimal reservoir hostsDonor bloodEpidemiological surveyHuman patientsImmune systemSerological assaysImmunodominant antigensInfectionInfectious diseasesIntraerythrocytic protozoan parasitePatientsImmunosorbent assay
2013
Chapter 14 Neurological manifestations of human babesiosis
Usmani-Brown S, Halperin JJ, Krause PJ. Chapter 14 Neurological manifestations of human babesiosis. Handbook Of Clinical Neurology 2013, 114: 199-203. PMID: 23829910, DOI: 10.1016/b978-0-444-53490-3.00014-5.Peer-Reviewed Original ResearchConceptsLevel of consciousnessRare complicationBlood transfusionNeurological manifestationsCommon symptomsNeurological dysfunctionFatal diseaseInfectious diseasesIntraerythrocytic protozoaHuman babesiosisDiseaseBabesiosisIxodid ticksTransfusionComplicationsHeadacheDysfunctionLethargyPathogenesisSymptoms
2012
Cellular basis for clearance of the protozoan parasite Babesia microti in immunocompromised hosts (43.13)
Vannier E, Silver Z, Wilson C, Su J, Chiam J, Laurie S, Telford S, Gelfand J, Krause P, Wortis H. Cellular basis for clearance of the protozoan parasite Babesia microti in immunocompromised hosts (43.13). The Journal Of Immunology 2012, 188: 43.13-43.13. DOI: 10.4049/jimmunol.188.supp.43.13.Peer-Reviewed Original ResearchCD4-/- miceB cellsT cellsMild flu-like illnessBabesia microtiResolution of parasitemiaAbsence of CD4Flu-like illnessRag1-/- miceRole of complementB-cell lymphomaCourse of infectionPrimary etiologic agentMature B cellsCD4-CD8Specific IgGAnti-CD20Athymic miceCell lymphomaFc receptorsHealthy individualsCD4ParasitemiaEtiologic agentInfectious diseases
2003
Successful Treatment of Human Granulocytic Ehrlichiosis in Children Using Rifampin
Krause PJ, Corrow CL, Bakken JS. Successful Treatment of Human Granulocytic Ehrlichiosis in Children Using Rifampin. Pediatrics 2003, 112: e252-e253. PMID: 12949322, DOI: 10.1542/peds.112.3.e252.Peer-Reviewed Original ResearchConceptsHuman granulocytic ehrlichiosisYears of ageSuccessful treatmentGranulocytic ehrlichiosisTick-borne infectious diseaseFlu-like illnessTreatment of choiceHospital admissionClinical featuresSerious infectionsInfectious diseasesPhagocytophilum infectionRifampinAnaplasma phagocytophilumPermanent stainingChildrenInfectionTreatmentEhrlichiosisAgeYearsAdmissionIllnessDiseaseDoxycycline
1994
Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America.
Dellinger E, Gross P, Barrett T, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America. Infection Control And Hospital Epidemiology 1994, 15: 182-8. PMID: 8207176, DOI: 10.1086/646887.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsInfectious Diseases SocietyPostoperative wound infectionProphylactic antimicrobial agentsDiseases SocietyWound infectionProphylactic antibioticsReliable administrationPediatric Infectious Diseases SocietyAntimicrobial agentsInfectious diseasesQuality Standards SubcommitteeSurgical infectious diseasesSurgical Infection SocietyClinical Affairs CommitteeMethod of administrationAntimicrobial prophylaxisPostoperative infectionPotential morbidityHospital epidemiologyOperative procedureSurgical proceduresOptimal doseApparent efficacyDrug AdministrationOptimal durationQuality Standard for Antimicrobial Prophylaxis in Surgical Procedures
Dellinger E, Gross P, Barrett T, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures. Infection Control And Hospital Epidemiology 1994, 15: 182-188. DOI: 10.2307/30145558.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPostoperative wound infectionProphylactic antimicrobial agentsInfectious Diseases SocietyDiseases SocietyWound infectionProphylactic antibioticsReliable administrationPediatric Infectious Diseases SocietyAntimicrobial agentsInfectious diseasesQuality Standards SubcommitteeSurgical infectious diseasesSurgical Infection SocietyClinical Affairs CommitteeMethod of administrationAntimicrobial prophylaxisPostoperative infectionPotential morbidityOperative procedureHospital epidemiologySurgical proceduresInfection controlOptimal doseApparent efficacyDrug AdministrationQuality Standard for Antimicrobial Prophylaxis in Surgical Procedures
Dellinger E, Gross P, Barrett T, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for Antimicrobial Prophylaxis in Surgical Procedures. Clinical Infectious Diseases 1994, 18: 422-427. PMID: 8011827, DOI: 10.1093/clinids/18.3.422.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPostoperative wound infectionProphylactic antimicrobial agentsInfectious Diseases SocietyDiseases SocietyWound infectionProphylactic antibioticsReliable administrationPediatric Infectious Diseases SocietyAntimicrobial agentsInfectious diseasesQuality Standards SubcommitteeSurgical infectious diseasesSurgical Infection SocietyClinical Affairs CommitteeMethod of administrationPostoperative infectionPotential morbidityHospital epidemiologyOperative procedureInfection controlOptimal doseApparent efficacyDrug AdministrationOptimal durationHospital pharmacists